Table 2 summarizes the diagnostic ability of PJC and/or KL-6 analysis to differentiate malignant disease (PDAC and IPMC) from benign disease (IPMN and pancreatic inflammatory lesion). Here, MUC1 is linked to pancreatic intraductal papillary-mucinous neoplasm.